Responses
Oral Presentations
Plenary session 3: Exploiting B cells and other cell types
03.04 Targeted disruption of tumor-borne GDF-15-mediated immunoresistance restores immune checkpoint inhibitor activity in last-line cancer patients
Compose a Response to This Article
Other responses
No responses have been published for this article.
